- Home
- DNUT vs ARCT Comparison
DNUT vs ARCT Comparison
Compare DNUT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNUT
- ARCT
- Stock Information
- Founded
- DNUT 1937
- ARCT 2013
- Country
- DNUT United States
- ARCT United States
- Employees
- DNUT N/A
- ARCT N/A
- Industry
- DNUT Food Chains
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- DNUT Consumer Staples
- ARCT Health Care
- Exchange
- DNUT Nasdaq
- ARCT Nasdaq
- Market Cap
- DNUT 563.2M
- ARCT 526.5M
- IPO Year
- DNUT 2021
- ARCT N/A
- Fundamental
- Price
- DNUT $4.16
- ARCT $8.64
- Analyst Decision
- DNUT Buy
- ARCT Buy
- Analyst Count
- DNUT 6
- ARCT 10
- Target Price
- DNUT $6.22
- ARCT $35.25
- AVG Volume (30 Days)
- DNUT 15.2M
- ARCT 2.2M
- Earning Date
- DNUT 11-06-2025
- ARCT 11-10-2025
- Dividend Yield
- DNUT 1.68%
- ARCT N/A
- EPS Growth
- DNUT N/A
- ARCT N/A
- EPS
- DNUT N/A
- ARCT N/A
- Revenue
- DNUT $1,534,272,000.00
- ARCT $122,122,000.00
- Revenue This Year
- DNUT N/A
- ARCT N/A
- Revenue Next Year
- DNUT $0.45
- ARCT $26.81
- P/E Ratio
- DNUT N/A
- ARCT N/A
- Revenue Growth
- DNUT N/A
- ARCT N/A
- 52 Week Low
- DNUT $2.50
- ARCT $7.93
- 52 Week High
- DNUT $12.27
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- DNUT 61.24
- ARCT 29.91
- Support Level
- DNUT $3.46
- ARCT $9.36
- Resistance Level
- DNUT $4.50
- ARCT $10.12
- Average True Range (ATR)
- DNUT 0.43
- ARCT 1.04
- MACD
- DNUT 0.02
- ARCT -0.47
- Stochastic Oscillator
- DNUT 52.11
- ARCT 4.24
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.